Voxel, a market leader in diagnostic services, is committed to continuous development, expanding the scope of its operations and establishing partnerships with organisations that will work on solutions designed to improve the quality and competitiveness of services in the medical imaging market.
The content on the VOXEL S.A. website (hereinafter: “the Website”) is of a general nature and is provided for information purposes only. None of the information published on the Website constitutes medical advice or an offer within the meaning of the Civil Code. VOXEL S.A. (hereinafter: “the Company”) makes every effort to ensure that the information published on the Website is complete and up to date; however, it expressly disclaims any liability for any loss or damage arising from the use of this information, or from any incompleteness or errors therein. The Company accepts no responsibility for the content of websites linked to this Website. Anyone wishing to obtain detailed information about the Company and the services it provides is requested to contact the Company directly.
The content and structure of the Website are protected under intellectual property and competition law, including, in particular, the Act of 4 February 1994 on Copyright and Related Rights (Journal of Laws 2006.90.631 – consolidated text, as amended), the Act of 30 June 2000 on Industrial Property Rights (Journal of Laws 2013.1410 – consolidated text), the Act of 27 July 2001 on the Protection of Databases (Journal of Laws 2001.128.1402, as amended) and the Act of 16 April 1993 on Combating Unfair Competition (Journal of Laws 2003.153.1503 – consolidated text, as amended). All rights to the materials published on the Website are reserved by the Company, unless otherwise stated, and their use, in whole or in part, for any purpose other than personal use, requires the Company’s express, prior, written consent.
The provision of any personal data on the Website is voluntary. The personal data collected will not be disclosed to third parties. The data controller is VOXEL S.A., with its registered office at ul. Wielicka 265, 30-663 Kraków.
VOXEL S.A. holds trade mark registration No. 230543 for the trade mark ‘VOXEL’ (application No. Z-355680), which may be used to designate the following classes of goods: 10 radiological screens for medical purposes; radiological apparatus for medical purposes; radiotherapy equipment; diagnostic apparatus for medical purposes; 42 research and development; research in the field of physics; 44 medical clinics; non-hospital medical care facilities; medical assistance.”
VOXEL operates an Integrated Management System in accordance with ISO 9001:2015, ISO 14001:2015 oraz ISO/IEC 27001:2013.
The scope of certification covers the provision of medical services in the field of diagnostic imaging.
The annual external audits carried out by the certification body TŰV Rheinland Polska Sp. z o.o. are successfully completed, thereby confirming the high standard of our services, which prioritise patients’ well-being whilst ensuring information security and protecting the environment.
Authorised Representative for the Integrated Management System – Aneta Stolarz, tel.: 531 403 078. a.stolarz@voxel.pl
The impact on human health and the environment of activities involving exposure to ionising radiation carried out by Voxel S.A.
In accordance with Article 32c(2) of the Atomic Energy Act, we hereby inform you that activities involving exposure to ionising radiation, as referred to in Article 4(1)(1) or (4)–(16) of the Atomic Energy Act, carried out under licences granted to Voxel S.A., issued by the President of the National Atomic Energy Agency, do not adversely affect human health
or the environment. We also wish to inform you that the performance of these activities does not result in the release of radioactive substances into the environment.
The purpose of this notice is to explain matters relating to the digitisation of our patients’ paper medical records.
Pursuant to Article 13b of the Act of 28 April 2011 on the healthcare information system, a healthcare provider may convert medical records maintained and stored in paper form into electronic form, hereinafter referred to as ‘the digitisation of medical records’.
Voxel S.A., as a healthcare provider, digitises paper medical records generated in connection with the examinations it carries out. The digitisation process involves scanning the paper medical records, applying the appropriate electronic signature to them, and storing the records in electronic form.
Documents produced as a result of digitisation are equivalent to the originals.
The patient has the right to collect the originals of their paper medical records once they have been digitised. Refusal to collect the paper medical records will entitle Voxel S.A. to permanently destroy the paper records in such a way as to prevent the patient from being identified.
It should be borne in mind that, despite the digitisation of paper medical records, patients still have the right to access their medical records.